Introduction

Spaceflight Associated Neuro-Ocular Syndrome (SANS) refers to a range of neuro-ocular changes experienced by astronauts during long duration space flight (LDSF) missions. The findings in SANS include optic disc edema [1], globe flattening [2], choroidal folds [3], and refractive error shift [4]. Although the exact etiology of SANS is not fully understood it may be multifactorial, involving alterations in cephalad intraorbital, intraocular, and intracranial fluid shifts and secondary changes in tissue and fluid dynamics due to microgravity. Ocular immunology plays a crucial role in maintaining normal eye health by defending against infections. However, spaceflight conditions can disrupt the immune system and may affect the regulation of intracranial, intraorbital, and intraocular pressure. Hence, understanding the relationship between ocular immunology and SANS may be a potential mechanism for developing effective countermeasures to protect astronauts’ ocular health during LDSF.

Ocular immunology and spaceflight

Crucian et al. [5] explored the dynamics of plasma cytokine levels in astronauts during long-duration spaceflight aboard the International Space Station (ISS). The study collected plasma samples from 28 crewmembers at multiple time points pre-flight, in-flight, and post-flight with a focus on understanding immune system changes and potential health risks associated with space travel [5]. Samples were collected at various intervals, including before, during, and after spaceflight, to capture changes in cytokine levels [5]. It was found while baseline cytokine levels were generally low, spaceflight induced notable increases in certain cytokines, particularly interleukin-8 (IL-8) and TNFα, suggesting a mild inflammatory response [5]. Elevated levels of chemokines such as CCL2, CCL4, and CXCL5 further supported the presence of chronic inflammation during spaceflight [5]. Interestingly, plasma levels of IL-1ra, an inhibitor of the proinflammatory effects of IL-1, were consistently elevated during spaceflight. This increase may represent an adaptive physiological response to inflammatory stress [5]. The study highlights the importance of monitoring cytokine levels as biomarkers for assessing immune system health and the potential health risks associated with long-duration space missions [5].

Some studies have suggested that SANS may be associated with ocular immune alterations (e.g., increase in cytokine production and ocular inflammation) [6]. Additionally, SANS has been linked to changes in ocular blood flow and fluid dynamics, which can lead to optic disc edema and visual impairment [7]. The precise mechanisms underpinning SANS pathophysiology are not fully understood, but they are likely to involve a combination of microgravity-induced changes in fluid dynamics, radiation exposure, and oxidative stress [8,9,10,11].

The ocular immune system is responsible for maintaining ocular homeostasis and protecting the eye from infections [12]. Spaceflight-induced immune system alterations include an increase in pro-inflammatory cytokines and a decrease in anti-inflammatory cytokines [6]. One study analyzed blood samples from astronauts who experienced SANS during spaceflight and found alterations in serum cytokine profiles [5]. Specifically, increased levels of the pro-inflammatory cytokine interleukin-6 (IL-6) and decreased levels of the anti-inflammatory cytokine interleukin-10 (IL-10) were observed in astronauts with SANS compared to those without SANS [5].

Microgravity-induced changes can lead to a decrease in the number of lymphocytes and monocytes, thereby impairing immune function [12]. Studies have demonstrated that spaceflight diminishes cytokine production, rendering astronauts more susceptible to infections [13]. This was highlighted in a study in Rooney et al. [14] which identified a potential link between spaceflight-induced stress and immune dysregulation, and contributed to the reactivation of latent herpes viruses in astronauts. The study found increased shedding of these viruses in body fluids during and after missions, highlighting the potential health risks associated with viral reactivation upon return to Earth [14]. Interestingly, it was found that stress-induced immune dysregulation in space may contribute to this viral reactivation [14]. Table 1 lists the prior studies on systemic and ocular inflammation in SANS.

Table 1 Summary of studies on the relationship between Systemic and Ocular Immunology and Inflammation with SANS.
Full size table

Conclusion

Overall, the intricate interplay between ocular immunology and the space environment underscores the complex pathophysiology of SANS. The observed increase in pro-inflammatory cytokines coupled with a decrease in anti-inflammatory cytokines suggests a dysregulation of the ocular immune system in spaceflight conditions. These alterations may contribute to optic disc edema, visual impairment, and possibly increased susceptibility to infections. Future studies could explore the specific mechanisms underlying immune dysregulation in microgravity environments, including the role of stress and its impact on viral reactivation. Additionally, longitudinal studies tracking immune parameters before, during, and after space missions may provide valuable insights into the dynamic changes occurring in the ocular immune system.